Clinical Trials Logo

Recession, Gingival clinical trials

View clinical trials related to Recession, Gingival.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06037161 Recruiting - Recession, Gingival Clinical Trials

Comparison of Two Methods of Covering a Single Lower Front Tooth With Receded Gums

Start date: May 19, 2023
Phase: N/A
Study type: Interventional

The primary objective of this randomized clinical trial is to compare the mean root coverage achieved with Coronally Advanced Flap (CAF) + Connective Tissue Graft (CTG) (control) to Gingival Pedicle Split Thickness flap (GPST) + CTG (test) for the treatment of isolated gingival recession defects in mandibular incisors. The secondary objectives are to compare the percentage of complete root coverage and keratinized tissue gain between the two techniques.

NCT ID: NCT05961566 Recruiting - Recession, Gingival Clinical Trials

Palatal Volumetric Change Analysis Following Connective Tissue Graft With and Without Donor Site Augmentation

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

The goal of this randomized clinical trial is to compare whether soft tissue augmentation placed in the donor site following a gum graft harvesting leads to volumetric changes compared to non-augmented sites in the palate. The main questions it aims to answer are: - Are there tissue thickness changes between the two groups (control group and augmentation group)? - Are there volumetric changes in the donor site (palate) between the two groups in the short and long term? Participants will receive a gum graft and then based on what group they were randomly assigned, they will receive either a collagen matrix where the gum graft was taken (on the palate) or nothing will be placed. Researchers will compare non-augmented sites with augmented sites to see if there is a change in tissue thickness and volume.

NCT ID: NCT05565079 Recruiting - Recession, Gingival Clinical Trials

Root Coverage Using ADM and Coronally Positioned Tunnel With or Without Enamel Matrix Derivative

Start date: October 6, 2022
Phase: Phase 4
Study type: Interventional

24 patients will be treated with a coronally positioned tunnel with AlloDerm RTM with or without the addition of Enamel Matrix Derivative to compare the baseline and 6-month changes in recession defect coverage, clinical attachment levels, amount of keratinized tissue width, and soft tissue thickness.